Jpmorgan Chase & CO Iradimed Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Iradimed Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 29,226 shares of IRMD stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,226
Previous 17,175
70.17%
Holding current value
$1.57 Million
Previous $754,000
94.83%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IRMD
# of Institutions
141Shares Held
6.6MCall Options Held
0Put Options Held
0-
Nine Ten Capital Management LLC Evanston, IL906KShares$48.5 Million13.77% of portfolio
-
Black Rock Inc. New York, NY818KShares$43.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny539KShares$28.9 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA514KShares$27.5 Million0.0% of portfolio
-
Copeland Capital Management, LLC422KShares$22.6 Million0.38% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $673M
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...